Shiitake Mushrooms: Traditional Uses, Food Studies and Medicinal Extracts

What is shiitake?

Shiitake is Lentinula edodes, an edible mushroom that grows on hardwood. The cap and stem used in cooking are its fruiting body. Mycelium is the fungus's growing thread network; manufacturers also cultivate this material to make supplements.

Several different preparations appear in research. Lentinan is a beta-glucan, a complex carbohydrate isolated from shiitake. Lentinex is a named soluble beta-glucan preparation from mycelium. AHCC is a standardized cultured-mycelium extract composed mainly of alpha-glucans. Their manufacturing, composition and studied amounts differ. Food, oral extracts and injectable medicinal lentinan are distinct interventions. ^[1], ^[2], ^[3]

Historical uses and modern preparations

Shiitake has a long history as both food and a valued medicinal ingredient in East Asia. FAO's forestry account^[1] traces its cultivation to Song-dynasty China and describes the later refinement of cultivation in Japan. Growers inoculated suitable hardwood logs, managed moisture and shade, and harvested recurring crops. Drying preserved mushrooms for storage and trade. The same account records an “elixir of life” reputation in China and Japan.

Within Chinese dietary medicine, shiitake is described as sweet and neutral. Neutral refers to its place in a traditional classification of warming and cooling foods. Hong Kong's Chinese Medicine Regulatory Office^[4] describes dried shiitake as supporting the spleen and stomach, supplementing qi and benefiting the kidney, particularly for poor appetite and a weak constitution. These are traditional concepts about nourishment and function, rather than claims that eating shiitake treats disease in the anatomical spleen or kidney.

Modern research asks more specific questions: whether cooked mushrooms alter immune measurements, whether a named extract helps an infection clear, and whether lentinan adds benefit to cancer treatment. Beta-glucan research helps explain the scientific interest, but a measured immune-cell change is a different finding from the traditional idea of restoring qi.

Why do people take shiitake?

Shiitake can be an ordinary food choice. Supplements have been investigated for narrower medical questions, with results that depend on the preparation and outcome.

How should you compare extracts?

The label should identify the species, fruiting body or mycelium, and the named extract where applicable. Dried whole-mushroom powder, AHCC, Lentinex and other mycelial extracts have different compositions; their milligrams cannot be substituted directly.

Medicinal lentinan research^[5] includes injections and specialized oral preparations. An injection bypasses digestion, so its findings do not establish what happens after swallowing an ordinary powder capsule. In blends, individual ingredient amounts matter: the total mushroom weight does not reveal the shiitake exposure.

What are the drawbacks?

Shiitake dermatitis

Shiitake dermatitis is a distinctive itchy rash with streaks resembling whip marks. A 2026 case report^[6] described a 25-year-old man whose rash began two days after eating undercooked shiitake. Two people in the 2015 food study also withdrew because of dermatitis attributed to insufficient cooking. The broader case literature^[5] includes reactions after reportedly cooked mushrooms, so rehydrating and cooking food mushrooms according to package directions reduces an avoidable preparation problem without guaranteeing that everyone can tolerate them.

Bleeding and medicines

The antiplatelet concern has a laboratory basis: a 2004 experiment^[7] found that shiitake essential oil and its sulfur compound lenthionine inhibited platelet aggregation, the clumping involved in blood clotting. It did not measure bleeding in people taking oral supplements. The size of any added risk with anticoagulant or antiplatelet medicines is therefore unknown. People taking those medicines should review concentrated shiitake products with their pharmacist or prescriber; there is no validated high-dose cutoff from this experiment.

What did the food study show?

The 2015 dietary study^[8] reported enrolling 52 healthy adults aged 21–41. Participants were assigned 5 or 10 g of dried shiitake daily for four weeks, with instructions to rehydrate and cook it; 42 were included in the reported analysis. Researchers measured cultured blood-cell responses, saliva markers and inflammation-related measures.

Several measurements changed, including greater activity in certain T-cell populations, more salivary secretory IgA, an antibody involved in mucosal defense, and lower C-reactive protein, an inflammation marker. Most comparisons pooled the two mushroom groups. With no group eating no mushrooms, the study cannot reliably separate the food's contribution from other changes over time.

The groups also logged symptoms: there were 18 reports in each group and 38 versus 40 symptom-days, with no significant difference. These were symptom logs, not a demonstrated reduction in diagnosed infections. The study was funded by mushroom-industry organizations and the University of Florida agricultural institute.

What do mycelial extracts and lentinan studies show?

Lentinex and immune cells

A double-blind crossover trial^[2] assigned 42 healthy older adults to oral Lentinex or placebo for six weeks, followed by a four-week washout and the other treatment. The studied amount was 2.5 mg daily. B cells, immune cells that produce antibodies, increased with Lentinex, with a significant difference in change between treatments. Natural killer cells increased in both groups, without a significant difference between them; measured antibodies and other immune-response proteins did not change. Safety blood tests and reported adverse events were similar to placebo. This trial measured immune responses rather than fewer infections.

AHCC and persistent HPV

A phase II trial^[3] randomized 50 women over 30 with high-risk human papillomavirus (HPV) persisting for more than two years. They received 3 g AHCC daily for six months followed by placebo, or placebo for twelve months. Forty-one completed the study.

Among completers, 14 of 22 taking AHCC tested negative for HPV RNA and DNA after six months; 2 of 19 placebo participants tested negative at twelve months. Nine of the 14 AHCC responders remained negative after stopping, although the paper describes the duration of that sustained response inconsistently. The small sample, missing participants and differently timed comparisons limit confidence. Negative HPV tests were the outcome; cancer prevention was not tested.

Adverse events were mild and no participant stopped because of them. NIH funded the study; the manufacturer supplied AHCC and placebo, and the lead investigator disclosed earlier research grants from that company.

AHCC: immune measurements and vaccination

In a four-week randomized trial^[9], 21 healthy volunteers received 3 g AHCC daily or placebo. AHCC increased some dendritic-cell counts and a laboratory measure of immune-cell response. Dendritic cells help present foreign material to other immune cells. Natural killer-cell activity, another stimulated T-cell response and cytokine production did not differ between groups. The result was selective, rather than an improvement across the immune system.

A separate trial of 30 healthy adults^[10] studied 3 g AHCC daily starting immediately after seasonal influenza vaccination, with blood testing three weeks later. The percentage of CD8 T cells, which help destroy infected cells, increased more with AHCC. Influenza B antibody levels improved within the AHCC group, but the abstract does not provide a clear numerical between-group antibody comparison. The reported natural-killer-T-cell result used a looser statistical threshold and should not be treated as a clear benefit. These were immune measurements; the trial did not establish that participants caught less influenza.

AHCC and alcohol-related liver enzymes

A twelve-week trial^[11] randomized 69 people with fatty liver and mildly elevated alcohol-related liver enzymes to 1 g AHCC daily, 3 g daily or placebo; 62 completed it. ALT, a blood enzyme used to assess liver injury, fell by about 24% in each AHCC group versus a 4% rise with placebo. That percentage-change comparison was significant, but absolute enzyme levels at twelve weeks and changes in the other two liver enzymes were not significantly different between groups. Fatigue and stress scores also did not differ.

The manufacturer funded the study and supplied the capsules. These short-term laboratory results do not establish protection against cirrhosis.

Lentinan and cancer adjunct treatment

The cancer evidence includes favorable older findings and an important later failure. A 2009 analysis^[12] combined individual data from five randomized trials involving 650 people with advanced gastric cancer. Adding lentinan to chemotherapy was associated with better survival: the hazard ratio was 0.80, with a 95% confidence interval of 0.68–0.95, indicating a lower rate of death over follow-up in that analysis.

However, a later phase III trial^[13] randomized 309 patients to S-1 chemotherapy alone or S-1 plus lentinan. Median survival was 13.8 versus 9.9 months, without a statistically significant difference. Time to treatment failure was significantly shorter with lentinan: 2.6 versus 4.3 months. A favorable biomarker subgroup did not change the negative overall result.

A 2026 systematic review^[14] of varied shiitake-derived cancer preparations found that tumors responded to treatment more often in the combined results, but no clear survival or quality-of-life benefit. Low-certainty evidence and differing preparations limit the conclusion. These reviews include studies already discussed; they are not additional independent trials. Much of the medicinal lentinan literature uses injections alongside cancer treatment.

Oral extracts have their own negative findings. In a six-month prostate-cancer study^[15], none of 61 assessable men taking a named mycelial extract achieved the specified PSA response, a drop exceeding 50% in prostate-specific antigen. Twenty-three progressed. The study had no control group, and stable PSA in some men did not establish a treatment effect.

Oral mycelium extract and chemotherapy numbness

A 45-person randomized trial^[16] tested an oral hot-water mycelial extract for numbness after oxaliplatin chemotherapy. Participants received placebo, 300 mg twice daily or 900 mg twice daily for twelve weeks. The lower-dose primary comparison was negative. The higher-dose group had a larger numerical improvement, but its comparison with placebo also missed statistical significance; pain comparisons were negative. A rash considered treatment-related occurred in the higher-dose group. The manufacturer funded the trial.

Cholesterol, triglycerides and gut bacteria

A 68-person randomized trial^[17] studied shiitake food bars for 66 days in people with borderline lipid elevations. The shiitake group had a reported 10% triglyceride reduction, along with favorable antioxidant-marker changes. The abstract does not make clear whether that triglyceride comparison was against placebo or the group's starting value, so it cannot establish a treatment advantage by itself.

A separate trial of 52 adults^[18] with mild high cholesterol used 10.4 g daily of a shiitake mixture delivering 3.5 g beta-glucans in food creams for eight weeks. It found no significant improvement in cholesterol or other lipid measures compared with placebo. Several inflammation markers were also unchanged. Gut-bacterial composition shifted, but the significance of those changes remained uncertain. The studies therefore do not establish shiitake as a cholesterol-lowering treatment.

Mouthrinse research

Experimental shiitake mouthrinses are another route. Short studies of low-molecular-weight extracts found mixed effects on plaque and gum measurements, including a trial with no reduction in plaque scores. These are local mouth treatments, not evidence for swallowed capsules. ^[19], ^[20]

Bottom line

Shiitake is an established food with a long medicinal history. The supplement findings are narrower: selected immune measurements and some small clinical studies are favorable, while cancer-treatment results conflict and a cholesterol benefit remains unestablished. The preparation matters—an ordinary powder capsule cannot substitute for AHCC, Lentinex or medicinal lentinan. Enjoy cooked shiitake if it suits you, and take a new rash or allergic reaction seriously.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly